Suven Life Sciences Ltd
NSE:SUVEN

Watchlist Manager
Suven Life Sciences Ltd Logo
Suven Life Sciences Ltd
NSE:SUVEN
Watchlist
Price: 125 INR 0.68%
Market Cap: 27.3B INR
Have any thoughts about
Suven Life Sciences Ltd?
Write Note

Suven Life Sciences Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Suven Life Sciences Ltd
Cash Equivalents Peer Comparison

Comparables:
DIVISLAB
DCAL
WINDLAS
SYNGENE
I
INNOVACAP

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Suven Life Sciences Ltd
NSE:SUVEN
Cash Equivalents
â‚ą1.5B
CAGR 3-Years
59%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Cash Equivalents
â‚ą3.4B
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Cash Equivalents
â‚ą4.1B
CAGR 3-Years
14%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Windlas Biotech Ltd
NSE:WINDLAS
Cash Equivalents
â‚ą52.9m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Cash Equivalents
â‚ą857m
CAGR 3-Years
-49%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Suven Life Sciences Ltd's Cash Equivalents?
Cash Equivalents
1.5B INR

Based on the financial report for Jun 30, 2024, Suven Life Sciences Ltd's Cash Equivalents amounts to 1.5B INR.

What is Suven Life Sciences Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-9%

Over the last year, the Cash Equivalents growth was 1%. The average annual Cash Equivalents growth rates for Suven Life Sciences Ltd have been 59% over the past three years , -9% over the past five years .

Back to Top